Today

Agents

Chat

Arena

Discover

More

App

Repligen Q2 Adjusted EPS USD 0.54 Vs. IBES Estimate USD 0.45 - RGEN News | Rallies

Repligen Q2 Adjusted EPS USD 0.54 Vs. IBES Estimate USD 0.45

RGEN•2026-07-28

Repligen reports second-quarter results

Jul 28 (Reuters) - Repligen Q2 revenue USD 204 million vs. IBES estimate USD 201.5 million.

Q2 adjusted operating income USD 34 million

Related News

Esquire Financial Holdings Inc <ESQ.O>: Raymond James Raises Target Price to $140 From $130

ESQ•2026-07-28

ExxonMobil <XOM.N>: BofA Global Research cuts to neutral from buy; raises price objective to $158 from $154

XOM•2026-07-28

Harvard Apparatus Regenerative Technology posts update to financial calendar

HRGN•2026-07-28

Altimmune's drug meets main goal of mid-stage study for alcohol use disorder

ALT•2026-07-28

Brief-Commvault Systems Q1 Revenue USD 100 Million Vs. IBES Estimate USD 310.4 Million

CVLT•2026-07-28